On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...